Tempus AI(TEM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TEM Tempus AI

Closed 12-17 16:00:00 EST

38.95

-0.93

-2.33%

盘后39.13

+0.18+0.46%

19:59 EST

High40.90	Low38.68	Vol4.28M
Open40.00	D1 Closing39.88	Amplitude5.57%
Mkt Cap6.13B	Tradable Cap432.35M	Total Shares157.45M
T/O169.04M	T/O Rate38.55%	Tradable Shares11.10M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"TEM","market":"US","secType":"STK","nameCN":"Tempus AI","latestPrice":38.95,"timestamp":1734469200000,"preClose":39.88,"halted":0,"volume":4279485,"hourTrading":{"tag":"盘后","latestPrice":39.1289,"preClose":38.95,"latestTime":"19:59 EST","volume":50759,"amount":1976353.2948,"timestamp":1734483579357},"delay":0,"floatShares":11100000,"shares":157445683,"eps":-8.520075,"marketStatus":"Closed","change":-0.93,"latestTime":"12-17 16:00:00 EST","open":40,"high":40.9,"low":38.68,"amount":169041240.90945,"amplitude":0.055667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.520075,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734512400000},"marketStatusCode":5,"adr":0,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":39.88,"preHourTrading":{"tag":"盘前","latestPrice":40.2,"preClose":39.88,"latestTime":"09:29 EST","volume":37780,"amount":1513201.81108,"timestamp":1734445763766},"postHourTrading":{"tag":"盘后","latestPrice":39.1289,"preClose":38.95,"latestTime":"19:59 EST","volume":50759,"amount":1976353.2948,"timestamp":1734483579357},"volumeRatio":0.62356,"impliedVol":1.1979,"impliedVolPercentile":0.832},"requestUrl":"/m/hq/s/TEM","defaultTab":"news","newsList":[{"id":"2492154945","title":"Cathie Wood’s ARK Investment bought 317.6K shares of Tempus AI today","url":"https://stock-news.laohu8.com/highlight/detail?id=2492154945","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492154945?lang=en_us&edition=fundamental","pubTime":"2024-12-18 09:15","pubTimestamp":1734484520,"startTime":"0","endTime":"0","summary":"20:10 EST Cathie Wood’s ARK Investment bought 317.6K shares of Tempus AI (TEM) today Published first on TheFly – the ultimate source for real-time,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-bought-317-6k-shares-of-tempus-ai-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-bought-317-6k-shares-of-tempus-ai-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKK","BK4121","BK4588","TEM","BK4544"],"gpt_icon":0},{"id":"2492952074","title":"Tempus AI: New CMS Decision Provides Medicare Coverage for Clinical Use of Tempus Ecg-Af Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2492952074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492952074?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:35","pubTimestamp":1734442557,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nFWN3NI0KL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEM","BK4121"],"gpt_icon":0},{"id":"2492995797","title":"New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2492995797","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492995797?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:30","pubTimestamp":1734442200,"startTime":"0","endTime":"0","summary":"New decision establishes reimbursement for the clinical use of Tempus ECG-AF, reducing the financial burden of using AI to improve early detection of atrial fibrillation. Per the CMS policy to allow payment for certain Software as a Service  devices in the Hospital Outpatient setting, CMS has assigned associated procedure codes for assessments with assistive algorithms like Tempus’ ECG-AF  to APC 5734, which has a Medicare rate of $128.90, effective January 1, 2025. This ruling is expected to allow hospitals to receive reimbursement for using Tempus’ ECG-AF to help identify patients at increased risk of AF. Earlier this year, Tempus received 510 clearance from the FDA for the Tempus ECG-AF device, which was the first FDA clearance for an AF indication in the category known as \"cardiovascular machine learning-based notification software\" and paved the way for clinicians to use this innovative algorithm in the care of their patients.The Tempus ECG-AF algorithm is intended for use to anal","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fO9BwwxfjEovfg92LuteoA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f7d65a3f0c6c6dd8758ad5bf43f2ab74","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fO9BwwxfjEovfg92LuteoA--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f7d65a3f0c6c6dd8758ad5bf43f2ab74"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cms-decision-provides-medicare-coverage-133000458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ECG","PHH","TEM","BK4208","LU1894683348.USD","WRD","BK4129","LU1894683264.USD","BK4121","LU2346227817.USD","BK4588","CMS","BK4585","LU2637428348.USD"],"gpt_icon":1},{"id":"2492619509","title":"Personalis, Tempus AI Expand Collaboration to Biopharma Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2492619509","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492619509?lang=en_us&edition=fundamental","pubTime":"2024-12-17 00:25","pubTimestamp":1734366333,"startTime":"0","endTime":"0","summary":"Personalis  and Tempus AI  said Monday they have expanded their collaboration to the biopharma industry.Tempus is the exclusive commercial diagnostic partner for Personalis' NeXT Personal Dx minimal residual disease product for broad patient adoption in breast and lung cancers, as well as for immunotherapy monitoring across all solid tumors.The expanded collaboration allows Tempus to offer the product to pharmaceutical and biotech customers who are looking to bundle minimal residual disease testing with other Tempus offerings in a given study, the companies said.Price: 3.90, Change: +0.08, Percent Change: +2.09","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PSNL","BK7095","TEM","TEM.AU","BK4121"],"gpt_icon":1},{"id":"2492261674","title":"Stock Market Today: Dow Jones Up As Bitcoin Play Pops; Cathie Wood Loads Up On This AI Stock Amid 48% Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=2492261674","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492261674?lang=en_us&edition=fundamental","pubTime":"2024-12-17 00:06","pubTimestamp":1734365182,"startTime":"0","endTime":"0","summary":"The Dow Jones was steady on the stock market today. A Bitcoin play rose on a Nasdaq move. Cathie Wood bought a plunging AI stock.","market":"nz","thumbnail":"https://www.investors.com/wp-content/uploads/2024/12/SMT-CathieWood-121624-news-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/12/SMT-CathieWood-121624-news-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.investors.com/market-trend/stock-market-today/dow-jones-nasdaq-sp500-bitcoin-cathie-wood-palantir-nvidia-super-micro/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["03042","BTC.USD.CC","TER","TER.AU","BEAM","ARKK","MSTR","NVIW.SI","03008","09439","NKE","NVDX","TEM.AU","3NVD.UK","CRSP","BTC.USD.HKCC","QID","TSYW.SI","03439","FFTY","SQQQ","NVDU","NVDS.UK","09008","USAW.SI","83042","NVD","MSTR.AU","HON","NQmain","TEM","TQQQ","NVDD","09042","PSQ",".IXIC","AVGO","2NVD.UK","QLD","MNQmain","SNVD.UK","NVDA"],"gpt_icon":1},{"id":"2491915693","title":"Personalis and Tempus Expand Collaboration to Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2491915693","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491915693?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:00","pubTimestamp":1734354002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUABRVJNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","PSNL","TEM"],"gpt_icon":0},{"id":"2491804696","title":"Personalis and Tempus Expand Collaboration to Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2491804696","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491804696?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:00","pubTimestamp":1734354000,"startTime":"0","endTime":"0","summary":"Expanded collaboration to yield greater biopharma access to Personalis’ MRD solution. FREMONT, Calif., December 16, 2024----Personalis, Inc.  and Tempus AI, Inc.  announced today that the companies have expanded their commercial relationship. The companies agreed in November 2023 to collaborate and bring ultra-sensitive MRD testing to market and launched their efforts at the 2024 American Society of Clinical Oncology  Annual Meeting. Tempus is serving as the exclusive commercial diagnostic partner for Personalis’ ultra-sensitive tumor-informed MRD product, NeXT Personal Dx, for broad patient adoption in breast and lung cancers, and for immunotherapy monitoring across all solid tumors.This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this press release that are not historical are \"forward-looking statements\" within the meaning of U.S. securities laws, including statements relating to the a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_keeebM0yCNKyDwLc9yXsg--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/1f186dc4bb39b969a0350ca779109c5b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_keeebM0yCNKyDwLc9yXsg--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/1f186dc4bb39b969a0350ca779109c5b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/personalis-tempus-expand-collaboration-biopharma-130000944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","PSNL","TEM"],"gpt_icon":0},{"id":"2491359871","title":"Insiders own 36% of Tempus AI, Inc (NASDAQ:TEM) in spite of selling recently and the recent dip may have hurt them","url":"https://stock-news.laohu8.com/highlight/detail?id=2491359871","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491359871?lang=en_us&edition=fundamental","pubTime":"2024-12-14 22:11","pubTimestamp":1734185462,"startTime":"0","endTime":"0","summary":"Insiders appear to have a vested interest in Tempus AI's growth, as seen by their sizeable ownership. If you want to know who really controls Tempus AI, Inc , then you'll have to look at the makeup of its share registry. With 36% stake, individual insiders possess the maximum shares in the company. Put another way, the group faces the maximum upside potential .Even though insiders have sold shares recently, the group owns the most numbers of shares in the company. As a result, the group bore the brunt of last week’s US$1.5b market cap loss.Let's delve deeper into each type of owner of Tempus AI, beginning with the chart below.NasdaqGS:TEM Earnings and Revenue Growth December 14th 2024. While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insiders-own-36-tempus-ai-141102370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","BK4588","BK4585","NVIW.SI","BK4112","TQQQ","QLD","NQmain","LU2095319765.USD","MNQmain","SQQQ","BK4121","QID","IE00BKPKM429.USD","TSYW.SI","IE00B3QW5Z07.USD",".IXIC","TEM","IE00B64PRP62.GBP","IE00BGHQF748.EUR","USAW.SI","NDAQ","LU2210149790.SGD","PSQ","LU2210150020.SGD"],"gpt_icon":1},{"id":"1152381505","title":"Tempus AI Director Theodore Leonsis sold 210,000 shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1152381505","media":"SEC Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152381505?lang=en_us&edition=fundamental","pubTime":"2024-12-14 07:25","pubTimestamp":1734132332,"startTime":"0","endTime":"0","summary":"Theodore Leonsis, Director of Tempus AI , conducted a series of transactions on December 11, 2024. He acquired 210,000 shares of Class A Common Stock through option exercise and subsequently sold a total of 210,000 shares at prices ranging from $40.73 to $43.19 per share. Such sales could indicate an executive's desire to adjust their ownership stake and should be closely monitored by investors.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI Director Theodore Leonsis sold 210,000 shares.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":1},{"id":"1138732654","title":"Form 4 | Tempus AI's Officer Phelps Erik sold 92916 Shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1138732654","media":"SEC Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138732654?lang=en_us&edition=fundamental","pubTime":"2024-12-14 07:25","pubTimestamp":1734132330,"startTime":"0","endTime":"0","summary":"Tempus AI's Officer Phelps Erik sold a total of 92,916 shares of Class A Common Stock on December 11 and 12, 2024, in multiple transactions with prices ranging from $40.30 to $44.20. Such significant share sales could potentially put some pressure on the company's stock price, and investors should closely monitor the situation.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":0},{"id":"1180422285","title":"Form 4 | Tempus AI's Officer Ryan Fukushima sold 120,000 Shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1180422285","media":"SEC Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180422285?lang=en_us&edition=fundamental","pubTime":"2024-12-14 07:25","pubTimestamp":1734132321,"startTime":"0","endTime":"0","summary":"Ryan Fukushima, the Chief Operating Officer of Tempus AI, Inc. , sold a total of 120,000 shares of the company's Class A Common Stock in four transactions on December 11, 2024. Specific trading details are as follows: 10,976 shares at $40.86; 32,026 shares at $41.7; 60,279 shares at $42.95; and 16,719 shares at $43.59. This series of intensive selling actions may indicate that the executive believes the company's stock price is currently overvalued. Investors should take note.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":0},{"id":"1118187101","title":"Tempus AI's Officer James W. Rogers sold 83,025 Shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1118187101","media":"SEC Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118187101?lang=en_us&edition=fundamental","pubTime":"2024-12-14 07:25","pubTimestamp":1734132312,"startTime":"0","endTime":"0","summary":"Tempus AI's Chief Financial Officer, James W. Rogers, disposed of a total of 83,025 shares of Class A Common Stock on December 11, 2024, through multiple transactions. The transaction prices ranged approximately from $40.30 to $43.78. Sale transactions by a Chief Financial Officer often indicate potential overvaluation of the stock, so investors should closely monitor the company's stock performance.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI's Officer James W. Rogers sold 83,025 Shares.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":0},{"id":"2491327113","title":"Wolfe Initiates Tempus AI at Outperform With $60 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2491327113","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491327113?lang=en_us&edition=fundamental","pubTime":"2024-12-13 21:20","pubTimestamp":1734096026,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $59.56, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"670c38e2dabfe7b5fce8741f03994740","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TEM"],"gpt_icon":0},{"id":"2491326774","title":"Wolfe starts ‘best-in-class’ Tempus AI with an Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2491326774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491326774?lang=en_us&edition=fundamental","pubTime":"2024-12-13 19:50","pubTimestamp":1734090614,"startTime":"0","endTime":"0","summary":"As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Tempus AI (TEM) with an Outperform rating and $60 price target T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/wolfe-starts-best-in-class-tempus-ai-with-an-outperform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":"670c38e2dabfe7b5fce8741f03994740","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/wolfe-starts-best-in-class-tempus-ai-with-an-outperform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM"],"gpt_icon":0},{"id":"1146539603","title":"Tempus AI, Inc., Director Red Sky Ventures LLC, 1.95M Shares Sold","url":"https://stock-news.laohu8.com/highlight/detail?id=1146539603","media":"SEC Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146539603?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:35","pubTimestamp":1734042923,"startTime":"0","endTime":"0","summary":"Red Sky Ventures LLC, a Director of Tempus AI, Inc., sold a total of 1,950,000 shares of Class A Common Stock on December 11, 2024, across two transactions at prices of $41.00 and $40.75 per share, respectively. After these transactions, Red Sky Ventures LLC holds 14,610,249 shares. The sale by a director may signal pessimism about the company's stock future, and investors should monitor closely.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":0},{"id":"2491331766","title":"Cathie Wood's ARK Sells $21.8M Tesla Shares, Buys $18.3M Tempus AI Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2491331766","media":"GuruFocus.com","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491331766?lang=en_us&edition=fundamental","pubTime":"2024-12-13 01:02","pubTimestamp":1734022943,"startTime":"0","endTime":"0","summary":"On Dec. 12, Ark Innovation , a company of Cathie Wood, disclosed its portfolio trades, showing how assets are moving from one Ark ETF to the next. The ARKK ETF sold 51,335 shares of Tesla Inc. , the biggest transaction of the day, with proceeds worth approximately $21.81 million. This trade implies that ARK is rebalancing its position as the leader in the electric vehicle market.Simultaneously, ARK became optimistic about Tempus's  outlook, adding 424,522 shares to its ARKK and ARKG ETFs for a total of $18.34 million. This purchase further affirmed ARK's bullish stance on the market impact artificial intelligence will have.In another notable move, ARKQ ETF sold 205,897 shares of Rocket Lab USA . Funds were reallocated to purchase 154,873 shares of Symbotic  for $4.13 million , or $4.81 million. ARK seemed interested in robotics and automation sectors, as this reflects.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/A2wMdJwuM6Ua0rRlAdbsjA--~B/aD0zNTg7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a435ffed6659b01b3c49b19e1012d253","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/A2wMdJwuM6Ua0rRlAdbsjA--~B/aD0zNTg7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a435ffed6659b01b3c49b19e1012d253"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cathie-woods-ark-sells-21-170223007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861559042.SGD","BK4588","LU1720051017.SGD","LU1720051108.HKD","LU1914381329.SGD","IE00BK4W5L77.USD","LU0097036916.USD","LU0823414478.USD","BK4516","IE00BJLML261.HKD","LU0316494557.USD","FDN","ARKK","LU1551013425.SGD","LU2756315318.SGD","TSLL","LU1435385759.SGD","LU1629891620.HKD","BK4533","IE00B1XK9C88.USD","BK4534","BK4592","IE00BSNM7G36.USD","LU1551013342.USD","LU1861220033.SGD","LU0943347566.SGD","LU1861558580.USD","TSYW.SI","BK4585","BK4121","BK4511","TSLA","LU1429558221.USD","LU0823411888.USD","SG9999015945.SGD","LU2023250330.USD","LU0820562030.AUD","BK4581","IE00BK4W5M84.HKD","LU0689472784.USD","BK4550","BK4598","LU0053666078.USD","TEM","SG9999015952.SGD","LU0466842654.USD","LU0082616367.USD","LU0719512351.SGD","LU2326559502.SGD","IE00BWXC8680.SGD"],"gpt_icon":1},{"id":"1122134864","title":"Stock Track | Tempus AI Stock Soars 5.12% Amid Conflicting Signals From Ark Invest Buying and Insider Selling","url":"https://stock-news.laohu8.com/highlight/detail?id=1122134864","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122134864?lang=en_us&edition=fundamental","pubTime":"2024-12-12 23:00","pubTimestamp":1734015627,"startTime":"0","endTime":"0","summary":"Shares of Tempus AI Inc. , a healthcare diagnostics company, experienced a significant surge of 5.12% in the intraday trading session on Thursday. This stock movement came amidst conflicting signals from prominent players in the market.On the bullish side, Cathie Wood's Ark Invest executed a substantial purchase of Tempus AI shares, acquiring 424,522 shares valued at approximately $18.3 million through its ARK Genomic Revolution ETF and ARKK funds. This move by the renowned investment firm signa","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TEM"],"gpt_icon":1},{"id":"1111533852","title":"Tempus AI Director Bradley A. Keywell sold 395,800 Shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1111533852","media":"SEC Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111533852?lang=en_us&edition=fundamental","pubTime":"2024-12-12 21:35","pubTimestamp":1734010518,"startTime":"0","endTime":"0","summary":"Tempus AI  Director Bradley A. Keywell conducted two sales of common stock on December 11, 2024, totaling 395,800 shares. The prices for the sales were $42.4899 and $43.1683 per share on average. Such large disposals by an insider often indicate that the stock might be overvalued, potentially serving as a bearish signal. Investors should closely monitor this development.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI Director Bradley A. Keywell sold 395,800 Shares.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":0},{"id":"1103591878","title":"Cathie Wood's Ark Invest Sells $21.8M Worth of Tesla Stock Amid Searing Rally, Bets On This AI Medical Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1103591878","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103591878?lang=en_us&edition=fundamental","pubTime":"2024-12-12 15:24","pubTimestamp":1733988254,"startTime":"0","endTime":"0","summary":"On Wednesday,Cathie Wood-ledArk Investexecuted significant trades involving$Tesla Inc.(TSLA)$and$Tempus AI Inc.(TEM)$ The investment firm opted to sell a substantial number of Tesla shares while incre","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","TSYW.SI","TSLA"],"gpt_icon":1},{"id":"2490819808","title":"Press Release: Flare Raises $30M Series B Led By Base10 Partners to Lead the Security Intelligence and Threat Exposure Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2490819808","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490819808?lang=en_us&edition=fundamental","pubTime":"2024-12-12 06:22","pubTimestamp":1733955720,"startTime":"0","endTime":"0","summary":"Flare Raises $30M Series B Led By Base10 Partners to Lead the Security Intelligence and Threat Exposure Markets. Investment will enable cybersecurity leader to tackle threat exposure management market. MONTREAL, Dec. 11, 2024 /PRNewswire/ - Flare, the global leader in Threat Exposure Management , announced today its USD $30 Million Series B Round led by Base10 Partners with participation from Inovia Capital, White Star Capital, and Fonds de solidarité FTQ. Flare has seen consistent traction with triple digit year over year growth in both 2023 and 2024.Industry analyst and cybersecurity thought leader Richard Stiennon, former Gartner VP and current Chief Research Analyst at IT Harvest, offers insight into the impact of Flare's innovations. \"With this investment round, Flare is well-positioned to enhance its exposure data collect","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","TEM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tempus.com","stockEarnings":[{"period":"1week","weight":-0.1424},{"period":"1month","weight":-0.2389},{"period":"3month","weight":-0.1899},{"period":"6month","weight":0.3149},{"period":"1year","weight":0.0778},{"period":"ytd","weight":0.0778}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0359},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.2929},{"period":"ytd","weight":0.2766}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Tempus AI","nameEN":"Tempus AI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempus AI(TEM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tempus AI(TEM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tempus AI,TEM,Tempus AI股票,Tempus AI股票老虎,Tempus AI股票老虎国际,Tempus AI行情,Tempus AI股票行情,Tempus AI股价,Tempus AI股市,Tempus AI股票价格,Tempus AI股票交易,Tempus AI股票购买,Tempus AI股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempus AI(TEM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tempus AI(TEM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}